| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Tularik Inc., South San Francisco, California 94080 [L. P., X. B. L., T. H.]; Tularik Inc., Genomics Division, Greenlawn, New York 11740 [Y. P., Y. Y., W. G. v. E., K. C. Q. N., S. P., J. L.]; and Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109 [M. R.]
We used cDNA-based genomic microarrays to examine DNA copy number changes in a panel of prostate tumors and found a previously undescribed amplicon on chromosome 17 containing a novel overexpressed gene that we termed prostate cancer gene 17 (PRC17). When overexpressed in 3T3 mouse fibroblast cells, PRC17 induced growth in low serum, loss of contact inhibition, and tumor formation in nude mice. The PRC17 gene product contains a GTPase-activating protein (GAP) catalytic core motif found in various Rab/Ypt GAPs, including RN-Tre. Similar to RN-Tre, we found that PRC17 protein interacts directly with Rab5 and stimulates its GTP hydrolysis. Point mutations that alter conserved amino acid residues within the PRC17 GAP domain abolished its transforming abilities, suggesting that GAP activity is essential for its oncogenic function. Whereas PRC17 is amplified in 15% of prostate cancers, it is highly overexpressed in approximately one-half of metastatic prostate tumors. The potent oncogenic activity of PRC17 is likely to influence the tumorigenic phenotype of these prostate cancers.
This article has been cited by other articles:
|
|
 |
|
  R. Vazquez-Martinez, A. J. Martinez-Fuentes, M. R. Pulido, L. Jimenez-Reina, A. Quintero, A. Leal-Cerro, A. Soto, S. M. Webb, N. Sucunza, F. Bartumeus, et al. Rab18 Is Reduced in Pituitary Tumors Causing Acromegaly and Its Overexpression Reverts Growth Hormone Hypersecretion J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2269 - 2276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Wainszelbaum, A. J. Charron, C. Kong, D. S. Kirkpatrick, P. Srikanth, M. A. Barbieri, S. P. Gygi, and P. D. Stahl The Hominoid-specific Oncogene TBC1D3 Activates Ras and Modulates Epidermal Growth Factor Receptor Signaling and Trafficking J. Biol. Chem., May 9, 2008; 283(19): 13233 - 13242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Frittoli, A. Palamidessi, A. Pizzigoni, L. Lanzetti, M. Garre, F. Troglio, A. Troilo, M. Fukuda, P. P. Di Fiore, G. Scita, et al. The Primate-specific Protein TBC1D3 Is Required for Optimal Macropinocytosis in a Novel ARF6-dependent Pathway Mol. Biol. Cell, April 1, 2008; 19(4): 1304 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Sklan, R. L. Serrano, S. Einav, S. R. Pfeffer, D. G. Lambright, and J. S. Glenn TBC1D20 Is a Rab1 GTPase-activating Protein That Mediates Hepatitis C Virus Replication J. Biol. Chem., December 14, 2007; 282(50): 36354 - 36361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Laketa, J. C. Simpson, S. Bechtel, S. Wiemann, and R. Pepperkok High-Content Microscopy Identifies New Neurite Outgrowth Regulators Mol. Biol. Cell, January 1, 2007; 18(1): 242 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Itoh and M. Fukuda Identification of EPI64 as a GTPase-activating Protein Specific for Rab27A J. Biol. Chem., October 20, 2006; 281(42): 31823 - 31831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Itoh, M. Satoh, E. Kanno, and M. Fukuda Screening for target Rabs of TBC (Tre-2/Bub2/Cdc16) domain-containing proteins based on their Rab-binding activity. Genes Cells, September 1, 2006; 11(9): 1023 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Arlt, W. Huber, U. Liebel, C. Schmidt, M. Majety, M. Sauermann, H. Rosenfelder, S. Bechtel, A. Mehrle, D. Bannasch, et al. Functional Profiling: From Microarrays via Cell-Based Assays to Novel Tumor Relevant Modulators of the Cell Cycle Cancer Res., September 1, 2005; 65(17): 7733 - 7742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gebhardt, U. Breitenbach, K. H. Richter, G. Furstenberger, C. Mauch, P. Angel, and J. Hess c-Fos-Dependent Induction of the Small Ras-Related GTPase Rab11a in Skin Carcinogenesis Am. J. Pathol., July 1, 2005; 167(1): 243 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Martinu, J. M. Masuda-Robens, S. E. Robertson, L. C. Santy, J. E. Casanova, and M. M. Chou The TBC (Tre-2/Bub2/Cdc16) Domain Protein TRE17 Regulates Plasma Membrane-Endosomal Trafficking through Activation of Arf6 Mol. Cell. Biol., November 15, 2004; 24(22): 9752 - 9762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Douglas, H. Fiegler, A. Rowan, S. Halford, D. C. Bicknell, W. Bodmer, I. P. M. Tomlinson, and N. P. Carter Array Comparative Genomic Hybridization Analysis of Colorectal Cancer Cell Lines and Primary Carcinomas Cancer Res., July 15, 2004; 64(14): 4817 - 4825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Oliveira, B.-L. Hsi, S. Weremowicz, A. E. Rosenberg, P. D. Cin, N. Joseph, J. A. Bridge, A. R. Perez-Atayde, and J. A. Fletcher USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst Cancer Res., March 15, 2004; 64(6): 1920 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pei, O. Wiser, A. Slavin, D. Mu, S. Powers, L. Y. Jan, and T. Hoey Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function PNAS, June 24, 2003; 100(13): 7803 - 7807. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
